Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.

Eva Wolf Christoph BoeseckeAnnamaria BaloghHelen BidnerChristiane CordesHans HeikenIvanka KrznaricTim KümmerleHans-Jürgen StellbrinkJochen SchneiderChristoph D Spinnernull null

Published in: AIDS research and therapy (2021)

EUDRA-CT Number 2015-000360-34; registered 07 April 2015; https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000360-34/DE .

Keyphrases